Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03012139 · ClinicalTrials.gov registry record
Cancer-Associated Muscle Atrophy and Weakness: An Investigation of Etiology
A clinical trial, sponsored by Mayo Clinic.
- Completed
- Registry status
- 31
- Enrollment target
NCT03012139: Completed study, sponsored by Mayo Clinic.
NCT03012139 is a clinical trial that has completed, run by Mayo Clinic. The registered enrollment target is 31 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03012139 has completed, sponsored by Mayo Clinic.
- COMPLETED
- Registry status
- 31 participants
- Enrollment target
Study Summary
This study is designed to gain a better understanding of the mechanisms leading to muscle wasting and metabolic abnormalities in skeletal muscle of cancer patients.
Primary Outcome
Muscle oxidative capacity will be measured by magnetic resonance spectroscopy
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 31 participants |
| Start Date | 2017-01 |
| Est. Completion | 2019-10-11 |
What the finished NCT03012139 record still lists
NCT03012139 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 31 participants, a relatively small participant target.
The record links to 0 conditions, and to 0 interventions.
NCT03012139 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03012139 about?
NCT03012139 is a clinical study titled "Cancer-Associated Muscle Atrophy and Weakness: An Investigation of Etiology". This study is designed to gain a better understanding of the mechanisms leading to muscle wasting and metabolic abnormalities in skeletal muscle of cancer patients.
What is the current status of trial NCT03012139?
This trial is currently completed. The enrollment target is 31 participants. The study started on 2017-01. Estimated completion is 2019-10-11.
Who is sponsoring clinical trial NCT03012139?
This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02932618 · 31 participants · Phase 3
A Study of Recombinant Von Willebrand Factor (rVWF) With or Without ADVATE in Children With Severe Von Willebrand Disease (VWD)
- NCT03482297 · 31 participants · Phase 1
Automated Abdominal Binder for Orthostatic Hypotension
- NCT04016389 · 31 participants · NA
FIGO 2018 Stage IB2 Cervical Cancer Treated With Neoadjuvant Chemotherapy Followed by Fertility Sparing Surgery
- NCT04211675 · 31 participants · Phase 1
NK Cells Infusions With Irinotecan, Temozolomide, and Dinutuximab
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia